| # | % | |||||
|---|---|---|---|---|---|---|
| 1 | ARIAD PHARMACEUTICALS INC | 12,850,000 | 94,961,000 | 26.95% | ||
| 2 | BIOGEN INC | 310,000 | 74,964,000 | 21.28% | ||
| 3 | MEDICINES CO | 1,752,000 | 58,919,000 | 16.72% | ||
| 4 | INTRA CELLULAR THERAPIES INC COM | 675,000 | 26,203,000 | 7.44% | ||
| 5 | PACIRA BIOSCIENCES INC | 653,000 | 22,025,000 | 6.25% | ||
| 6 | RAPTOR PHARMACEUTICAL CORP | 2,875,000 | 15,438,000 | 4.38% | ||
| 7 | ARRAY BIOPHARMA INC COM | 4,300,000 | 15,308,000 | 4.35% | ||
| 8 | QUEST DIAGNOSTICS INC | 159,000 | 12,944,000 | 3.67% | ||
| 9 | PERRIGO CO PLC | 100,000 | 9,067,000 | 2.57% | ||
| 10 | Apricus Biosciences, Inc. | 14,479,052 | 5,784,000 | 1.64% | ||
| 11 | ADVAXIS INC COM NEW | 600,000 | 4,853,000 | 1.38% | ||
| 12 | AEGERION PHARMACEUTICALS INC | 2,649,000 | 3,947,000 | 1.12% | ||
| 13 | ABBVIE INC | 50,000 | 3,095,000 | 0.88% | ||
| 14 | VIVUS INC | 2,573,943 | 2,882,000 | 0.82% | ||
| 15 | AVEO PHARMACEUTICALS INC | 2,000,000 | 1,922,000 | 0.55% |
Portfolio data is normalized using SEC Form 13F filings, including the Original 13F-HR (0001140361-16-076729, filed 2016.08.15).
From 2023-01-03 onward, the SEC requires values to be reported in nearest dollars. Earlier filings reported values in thousands; therefore, positions shown as $0 in older filings may represent actual values between $0–$999.
